By Fraiser Kansteiner
Mumbai, India-based pharma Wockhardt has signed up for fill-finish duties on AstraZeneca's Oxford-partnered COVID-19 shot, using a manufacturing site in Wales. It's setting aside capacity there for other candidates as well, as part of a broader deal to build out U.K. stores of vaccine hopefuls.
read more
By Eric Sagonowsky
Democratic Sen. Elizabeth Warren is asking the SEC to investigate Kodak stock trades made before the Trump administration announced a $765 million funding deal with the company. In a letter to agency Chairman Jay Clayton, she highlighted trades by company executives and others, questioning whether any were based on knowledge of the deal talks.
read more
By Robert King,Tina Reed
Tenet Healthcare announced $88 million in profits from the second quarter as provider relief funds offset major declines in patient volume.
read more
By Amirah Al Idrus
Even as it scrambled to pitch in against the COVID-19 pandemic, CureVac found itself embroiled in a game of executive musical chairs. Now, as it pushes an mRNA vaccine toward the clinic, it’s named a permanent chief, Franz-Werner Haas, and signed a Novartis alum, Igor Splawski, Ph.D. as its new top scientist.
read more
By Healthcare Staff
Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.
read more
By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner
The NIH is launching a test of monoclonal antibodies for COVID-19, starting with one from Eli Lilly. Four ex-FDA chiefs urged U.S. officials to press for blood plasma trials. A bipartisan group of AGs wants the feds to open Gilead Sciences's remdesivir to generic rivals. And Honeywell has one answer to a vaccine vial shortage.
read more
By Heather Landi
Even before the COVID-19 pandemic, patients faced barriers getting connected with the right mental health care services. The current health crisis is exacerbating these challenges and adding new ones. Here's what Quartet Health and SilverCloud Health are working on together to try to open up access to mental health care.
read more
By Fraiser Kansteiner
The glass used to make vials for vaccines and other medications is scarce, and with the looming need to store and distribute COVID-19 shots on a massive scale, Honeywell aims to step in with a new line of plastic alternatives dubbed Aclar Edge.
read more
By Ben Adams
As the pandemic rages on and clinical trials are becoming increasingly siteless, eSource trial firm Clinical Ink has become an M&A target, being bought up this week by GI Partners.
read more
By Angus Liu
Count Bayer as another company hurt by pandemic-related business slowdowns. During the second quarter, the company suffered from declines in its women’s health and ophthalmology departments, and the situation was only worsened by a newly implemented price cut in China.
read more
